FDA Drug Application (022071) for LAMISIL by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number022071
Product Number001
FormGRANULE;ORAL
DosageEQ 125MG BASE/PACKET
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMISIL
Active IngredientTERBINAFINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient TERBINAFINE2
List of drugs with Active Ingredient TERBINAFINE HYDROCHLORIDE3


Back to FDA Applications sponsored by NOVARTIS